High Vista Strategies LLC Mei Pharma, Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $79,979 - $115,678	-34,326 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $37,047 - $52,008	14,249 Added 70.97%	34,326 $98,000
Q1 2021 May 17, 2021	SELL	$2.73 - $4.5 $27,635 - $45,553	-10,123 Reduced 33.52%	20,077 $69,000
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $78,520 - $100,264	30,200 New	30,200 $80,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $372M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.